Table 1.
Type of Use | Type of Production | Polymer | Solvent | Bioactive Agent | Excipients | Cell Line/Animal | Ref. |
---|---|---|---|---|---|---|---|
Wound dressing | Single-needle solution ES | Starch-TPU | DMSO, DMF | - | - | NHDFs, Sprague Dawley rats | [80] |
Wound dressing | Single-needle solution ES | Functionalized CS | 80% AcOH | - | PEO (sacrificial polymer), 2-formylphenyl-boronic acid (imination reactant/reagent) |
NHDFs | [81] |
Wound dressing | Single-needle solution ES | Alginate/dextran and alginate/PEO | DW, pH 5.5 PBS |
- | PBS (conductivity); P407 and TX100 (surface tension) | NHDFs | [82] |
Wound dressing | Single-needle solution ES | PVDF, zP(S-r-4VP) zwitterionic copolymer |
DMF, acetone |
- | - | L929 mouse fibroblast cells, mice | [83] |
Wound dressing | Single-needle solution ES | SF/PCL | HFIP | - | CS and COL type I (coat) | NHDFs | [84] |
Wound dressing | Coaxial ES | DMF, DW | - | - | L929 mouse fibroblast cells, Albino Wister rats | [85] | |
Wound dressing | Single-needle solution ES | CS/PEO | 80% AcOH | - | HA (coat) | NHDFs | [86] |
Wound dressing | Single-needle solution ES | CS/PEO | 80% AcOH | - | - | NHDFs | [87] |
Wound dressing | Single-needle solution ES | GEL/PCL | HFIP | Ag and Mg ions | - | NHDFs, HUVECs, Sprague Dawley rats |
[88] |
Wound dressing | Single-needle solution ES | PVA/CS/starch | DW, AcOH | - | - | L929 mouse fibroblast cells | [89] |
Wound dressing | Single-needle solution ES | CS/PCL—HA/PEO bilayered scaffolds | Formic acid, acetone, DW | - | - | Vero cell (monkey epithelial cell line) | [90] |
Wound dressing | Single-needle solution ES | CS/PEO | AcOH, DW | - | Benzophenone (photoinitiator for photo-crosslinking) | - | [91] |
Wound dressing | Single-needle solution ES | PCL/COL | HFIP | - | - | Human foreskin fibroblasts, Sprague Dawley rats | [92] |
Wound dressing | Single-needle solution ES | CS/PVA | 80% AcOH, DW | - | NaBH4 solution (3D layered NF sponge creation) | 3T3 mouse fibroblasts, JB6 epidermal cells, C57BL/6 mice | [93] |
Wound dressing | Single-needle solution ES | VDF-TeFE/PVP | Acetone, isopropanol, DMF | ZnO | - | Wistar rats | [94] |
Wound dressing or implant coating | Single-needle solution ES | PET | TFA, DCM | Ag nanoparticles | - | AFSCs, CD1 mice |
[95] |
Skin tissue scaffold | Co-ES + electroblowing | Soy protein isolate/PEO—PEO | HFIP, ethanol | - | - | HDFBs, RAW 264.7 murine macrophage cell line | [96] |
Skin tissue scaffold | Hierarchical construction ES (Sandwich mode) | PLGA/SF | THF, DMF, formic acid | - | - | Human skin stem cells | [97] |
Skin tissue scaffold | Single-needle solution ES | PCL/silk sericin | TFE, formic acid | - | 3D-printed CS/sodium alginate hydrogel (bottom layer) | NHDFs | [98] |
Skin tissue scaffold | Single-needle solution ES | PCL | DCM, DMF | - | Poloxamer 407 | BMSCs (C57BL/6 mice) | [99] |
Tissue engineering scaffolds | Single-needle solution ES | EPU/SF | TFA | - | - | Fibroblast cells from human neonatal foreskin | [100] |
Tissue engineering scaffolds | Single-needle solution ES | PLA/CS | Chloroform, AcOH | - | - | GM07492 human fibroblast cells | [101] |
Tissue engineering scaffolds | Single-needle solution ES | PCL | HFIP | - | Neutralized COL (coat) | C57BL/6 mice, de-identified healthy small intestine tissues from discarded surgical samples of infant, teenager or adult | [102] |
Tissue engineering scaffolds | Wet ES (+CO2 foaming) |
PLA | Chloroform, DMF | - | - | NIH 3T3 fibroblasts | [103] |
Tissue engineering scaffolds | Coaxial ES | PU/CS | THF, DMF | - | PEO (co-spinning polymer of CS) | - | [104] |
Tissue engineering scaffolds | Single-needle solution ES | PCL | Acetone | Y2O3 nanoparticles | - | L-929 mouse fibroblast cells, UMR-106 rat osteoblast-like cells, Sprague Dawley rats | [105] |
Tissue engineering scaffolds | Single-needle solution ES | PCL | DCM, DMF | - | - | Green fluorescent protein (GFP)-labeled fibroblasts, rat neural progenitor cells, rats | [106] |
Tissue engineering scaffolds | Coaxial ES | PCL—core; PEG-NB—shell | HFIP | - | Irgacure 2959 (photoinitiator for UV polymerization) |
Bovine pulmonary artery endothelial cells, Sprague Dawley rats | [107] |
Tissue engineering scaffolds | Single-nozzle solution ES combined with extrusion-based 3D-printing technology | PS | DMF, THF | - | 85% phosphoric acid solution (doping agent) | - | [108] |
Tissue engineering scaffolds | Single-needle solution ES | PU/carbon nanotube composites | DMF | _ | _ | HUVECs | [109] |
Bladder tissue engineering scaffolds | Coaxial ES | PLCL—core; HA—shell | HFIP, formic acid |
- | - | Rat bladder smooth muscle cells, Sprague Dawley rats | [110] |
Bladder tissue engineering scaffolds | Single-needle solution ES | PLCL | HFIP | - | COL type I (coat) | hADSCs, Sprague–Dawley rats |
[111] |
Dura mater substitute | Near-field solution ES | n-octyl-2-cyanoacrylate | - | - | - | Harvested dura | [112] |
Dura mater substitute | Coaxial ES | Tetramethylpyrazine—core; PLGA—shell | Ethanol, HFIP | - | CS (PLGA/CS graft) | SH-SY5Y human neuroblastoma cells, fibroblasts | [113] |
Dura mater substitute (triple-layered) | Single-needle solution ES—inner and middle layer; melt-based electrohydrodynamic printing—outer layer | PCL | HFIP | Gentamicin—inner layer; nano-hydroxyapatite—outer layer | - | NHDFs, MC3T3-E1 cells | [114] |
Interface tissue engineering scaffolds | Single-needle solution ES | PCL | Chloroform, DMF | - | - | - | [115] |
Oral hard- and soft-tissue engineering scaffolds | Melt ES writing | PCL | - | - | - | MG63 human osteoblast-like cells, HaCaT keratinocyte cells, L929 fibroblast cells | [40] |
Bone tissue engineering scaffolds | Single-needle solution ES + melt ES writing | GEL—solution ES; PCL—melt ES writing | AcOH | - | - | Saos-2 cells | [116] |
Bone tissue engineering scaffolds | Modified free surface (bubble) ES | PVA | DW | - | Sodium dodecyl benzene sulfonates (surfactant) | - | [117] |
Bone tissue engineering scaffolds | Single-needle solution ES | HA/PEO, PVA | DW | TGF-β 2, Baicalein | - | - | [118] |
Bone tissue engineering scaffolds | Single-needle solution ES | CA/PCL | HFIP | - | CS (aerogel) | MC3T3-E1 murine osteoblast cells | [119] |
Artificial blood vessels | Single-needle solution ES | dPCU | HFIP | - | - | Sprague Dawley rats | [120] |
Artificial blood vessels | Multi-nozzle solution ES and co-ES | Bovine GEL/PCL | 20% AcOH, DMF, DCM | - | - | 3T3 mouse fibroblasts | [121] |
Artificial blood vessels | Single-needle solution ES—inner layer; co-ES—outer layer | RHC/PCL—inner layer; PCL—outer layer |
HFIP, ethanol |
- | PEO (sacrificial polymer) | HUVECs—inner layer; A7r5 rat smooth muscle cells—outer layer |
[122] |
Artificial blood vessels | Single-needle solution ES | PEUU | HFIP | Heparin | PEG (to earn PEUU@PEG-Hep grafts) | HUVECs, rats and New Zealand white rabbits |
[123] |
Artificial blood vessels | Coaxial ES | COL | DW | - | PVP (sacrificial polymer) | HUVECs | [124] |
Artificial blood vessels | Single-needle solution ES + magnetic environment—inner layer; double-nozzle ES—middle layer; single-needle solution ES—outer layer | PLCL/COL–PLGA/SF–PLCL/COL tri-layer graft | HFIP | - | - | HUVECs, smooth muscle cells, male nude mice |
[125] |
Cardiovascular stent coating | Coaxial ES | PU—core; PECA—shell | THF, DMF, acetone, DMSO | - | - | NIH-3T3 mouse fibroblasts, platelet | [126] |
Cardiovascular stent coating | Single-needle solution ES | Co-recombiner silk-elastin | TFE | - | - | HUVECs | [127] |
Drug-eluting stent coating | Single-needle solution ES | PCL/HSA | HFIP | Paclitaxel | Triethylamine | Rabbit iliac artery (drug-release study) | [128] |
Drug-eluting stent coating | Single-needle solution ES | CS/PEO/HPβCD | 90% AcOH | Simvastatin | - | HPMEC | [129] |
Drug-eluting stent coating | Single-needle solution ES | PLGA | HFIP | Vildagliptin | - | HUVECs, New Zealand white rabbits |
[130] |
Drug-eluting stent coating | Microfluidic ES | GelMA/PEGDA—inner layer; PCL—outer layer | DW, methanol, DCM |
Heparin, VEGF | Polydopamine (adherence enhancer), 2-hydroxy-2-methylpropiophenone (photoinitiator for photocrosslinking) |
HUVECs, HUASMCs, New Zealand white rabbits | [131] |
Respiratory mask | Nozzle-free ES (NTP120 setup) | PAN | DMF | Tea tree essential oil | Polyamidoamine dendritic polymers (drug delivery) | - | [132] |
Respiratory mask | Corona ES | PVDF | DMF, acetone |
- | - | - | [133] |
Respiratory mask | Single-needle solution ES | PCL | Acetone | - | - | - | [134] |
Abbreviations: AcOH—acetic acid, AFSC—human amniotic fluid stem cells, BMSCs—bone marrow mesenchymal stem cells, CA—cellulose acetate, COL—collagen, CS—chitosan, DCM—dichloromethane, DMF—N,N-dimethylformamide, DMSO—dimethyl sulfoxide, dPCU—degradable polycarbonate urethane, DW—deionized water, EPU—elastomeric polyurethane, ES—electrospinning, GEL—gelatin, GelMA—methylacrylated gelatin, HA—hyaluronic acid, hADSCs—human adipose-derived stem cells, HAS—human serum albumin, HDFBs—primary human dermal fibroblasts, HFIP—1,1,1,3,3,3-hexafluoro-2-propanol, HPβCD—2-hydroxypropyl-beta-cyclodextrin, HPMEC—human pulmonary microvascular endothelial cells, HUASMCs—human umbilical arterial smooth muscle cells, HUVECs—human umbilical vein endothelial cells, NF—nanofiber, NHDFs—normal human dermal fibroblasts, P407—Kolliphor P407 poloxamer, PAN—polyacrylonitrile, PBS—phosphate-buffered solution, PCL—polycaprolactone, PECA—Poly(ethyl2-cyanoacrylate), PEG-NB—polyethylene glycol norbornene, PEGDA—polyethylene glycol diacrylate, PEO—poly(ethylene oxide), PET—polyethylene terephthalate, PEUU—poly(ester urethane)urea, PLA—polylactic acid, PLCL—poly(l-lactide)/poly(e-caprolactone), PLGA—poly(lactic-co-glycolic acid), PS—polystyrene, PU—polyurethane, PVA—poly(vinyl alcohol), PVDF—poly(vinylidene fluoride), PVP—polyvinylpyrrolidone, RHC—recombinant human collagen peptides, Saos-2—human osteosarcoma cells, SF—silk fibroin, TFA—trifluoroacetic acid, TFE—tetrafluoroethylene, THF—tetrahydrofuran, TPU—thermoplastic polyurethane, TX100—Triton X-100, VDF-TeFE—vinylidene fluoride-tetrafluoroethylene copolymer, VEGF—vascular endothelial growth factor, Y2O3—Yttrium oxide, ZnO—zinc oxide.